Cornercap Investment Counsel’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,615
| Closed | -$740K | – | 527 |
|
|
2024
Q2 | $740K | Sell |
11,615
-110
| -0.9% | -$7.01K | 0.12% | 307 |
|
|
2024
Q1 | $811K | Hold |
11,725
| – | – | 0.12% | 306 |
|
|
2023
Q4 | $647K | Hold |
11,725
| – | – | 0.11% | 347 |
|
|
2023
Q3 | $681K | Sell |
11,725
-15
| -0.1% | -$871 | 0.12% | 334 |
|
|
2023
Q2 | $632K | Buy |
11,740
+559
| +5% | +$30.1K | 0.11% | 344 |
|
|
2023
Q1 | $444K | Buy |
+11,181
| New | +$444K | 0.08% | 427 |
|
|
2021
Q3 | – | Sell |
-36,818
| Closed | -$1.29M | – | 539 |
|
|
2021
Q2 | $1.29M | Buy |
+36,818
| New | +$1.29M | 0.14% | 203 |
|
|
2021
Q1 | – | Sell |
-9,315
| Closed | -$574K | – | 529 |
|
|
2020
Q4 | $574K | Buy |
+9,315
| New | +$574K | 0.08% | 375 |
|
|
2020
Q2 | – | Sell |
-6,361
| Closed | -$259K | – | 424 |
|
|
2020
Q1 | $259K | Sell |
6,361
-4,714
| -43% | -$192K | 0.05% | 369 |
|
|
2019
Q4 | $683K | Sell |
11,075
-100
| -0.9% | -$6.17K | 0.09% | 358 |
|
|
2019
Q3 | $814K | Sell |
11,175
-13,630
| -55% | -$993K | 0.12% | 343 |
|
|
2019
Q2 | $2.04M | Sell |
24,805
-2,975
| -11% | -$245K | 0.27% | 117 |
|
|
2019
Q1 | $1.96M | Sell |
27,780
-1,175
| -4% | -$82.9K | 0.27% | 118 |
|
|
2018
Q4 | $1.3M | Sell |
28,955
-805
| -3% | -$36.3K | 0.2% | 150 |
|
|
2018
Q3 | $1.68M | Buy |
29,760
+4,685
| +19% | +$265K | 0.22% | 139 |
|
|
2018
Q2 | $1.68M | Sell |
25,075
-825
| -3% | -$55.1K | 0.24% | 122 |
|
|
2018
Q1 | $1.51M | Buy |
25,900
+14,650
| +130% | +$853K | 0.21% | 138 |
|
|
2017
Q4 | $725K | Buy |
+11,250
| New | +$725K | 0.1% | 316 |
|